• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

CoMeDA Brings Compositional Rigor and Batch Correction to Microbiome Analysis

by
October 14, 2026
in Biology
Reading Time: 4 mins read
0
CoMeDA Brings Compositional Rigor and Batch Correction to Microbiome Analysis

CoMeDA Brings Compositional Rigor and Batch Correction to Microbiome Analysis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new web-based platform aims to fix one of the most persistent statistical blind spots in microbiome research. Called CoMeDA, the tool was developed by Cheng-Yang Lee and Tzu-Hao Chang of Taipei Medical University and described in the journal BMC Bioinformatics. It integrates compositional data analysis and batch effect correction into a single, coordinated workflow for metabarcoding studies, the kind of experiments that use 16S rRNA and ITS amplicon sequencing to profile bacterial and fungal communities. The platform is freely available online without registration, and a standalone Docker image allows researchers to deploy it on their own infrastructure.

The problem CoMeDA addresses begins with the nature of sequencing data itself. When researchers sequence amplicons from a microbial community, the read counts they obtain are inherently compositional: the abundance of each taxon is only meaningful relative to the others, because sequencing depth constrains the total. A species that appears to double in abundance may simply have declined less than its neighbors. Ignoring this compositional structure, the authors note, can produce spurious results in downstream analyses, a pitfall that has been documented repeatedly in the compositional data analysis literature yet is still not consistently handled in widely used microbiome platforms.

Compounding the issue is the batch effect problem. Multi-cohort studies, which combine samples processed at different times, in different laboratories, or on different sequencing platforms, frequently carry technical variation that can masquerade as biological signal. If a disease cohort happens to be sequenced in a different batch than the healthy controls, apparent differences in microbial composition may reflect the sequencing run rather than the disease. Batch effects, if not properly addressed, can confound the very signals researchers are trying to detect. Despite the availability of multiple microbiome analysis platforms, the authors argue, these two analytical considerations have not always been incorporated together as central, user-accessible components of a workflow.

CoMeDA treats the compositional structure of metabarcoding data and batch effects as coordinated components of one analytical pipeline rather than as optional add-ons. The platform accepts both raw FASTQ files and pre-classified taxa tables, making it compatible with short-read and long-read sequencing technologies alike. That flexibility matters as long-read platforms such as PacBio gain traction in microbiome research, since many existing tools were built around short-read data. For the crucial first steps of quality control and taxonomic assignment, users can start from raw reads or jump in with an already classified table.

At the statistical core of the platform is the centered log-ratio transformation, applied as the default normalization strategy. CLR transformation is a standard technique in compositional data analysis: it converts relative abundance data into log-ratios relative to the geometric mean of all taxa in a sample, placing the data in a space where ordinary statistical operations are more defensible. Before the transformation can be applied, however, the platform must contend with zeros, the many taxa that were simply not observed in a given sample. CoMeDA performs zero handling through probabilistic estimation, replacing true zeros with small estimated values so that log-ratios remain computable without distorting the underlying structure.

Once the data are normalized, CoMeDA applies automated batch effect correction that removes technical variation while preserving biological signals. The balance is delicate: overcorrection can erase genuine differences between conditions, while undercorrection leaves artifacts in place. The authors evaluated the behavior of this automated strategy using simulated datasets and a mock community with known ground truth, allowing them to assess how well the correction distinguished technical noise from real biology. They also used these benchmarks to measure the contribution of individual analytical components and the accuracy of taxonomic classification within the pipeline.

Downstream, the platform offers a suite of analyses that all operate within the same compositional framework. Diversity assessment uses compositionally appropriate metrics, and significance testing draws on established methods including PERMANOVA, PERMDISP, and ANOSIM, alongside principal coordinates analysis for visualization. Differential abundance analysis incorporates effect size estimation, and the platform supports approaches such as linear discriminant analysis effect size, robust centered log-ratio methods, and interquartile log-ratio transformations. Co-occurrence network inference and functional prediction, the latter covering both bacterial and fungal communities with reference to resources such as the Kyoto Encyclopedia of Genes and Genomes, round out the workflow. Because every step follows the same compositional logic, the results are internally consistent in a way that pieced-together pipelines often are not.

One of the platform’s more distinctive features is the split-CLR transformation, designed for cross-dataset analyses. When researchers want to combine datasets with different compositional structures, for example to run cross-kingdom correlation analyses linking bacteria and fungi, or paired-condition analyses within the same subjects, directly merging the data can introduce spurious correlations. Split-CLR addresses this by transforming each dataset appropriately before integration, reducing the artificial associations that arise from naive combination. This capability is particularly relevant to studies of polymicrobial diseases, where bacterial-fungal interactions may be clinically important but statistically treacherous to assess.

To demonstrate the platform in practice, the authors reanalyzed three published datasets spanning different study designs and sequencing technologies. A multi-cohort gout dataset allowed them to test batch correction across cohorts, and the analysis recovered biologically coherent patterns while highlighting additional findings supported by the literature, including distinctions related to hyperuricemia. A pediatric Crohn’s disease dataset covering both bacterial and fungal communities exercised the cross-kingdom analysis capabilities. Finally, a PacBio long-read periodontitis dataset confirmed compatibility with long-read data. Across all three, CoMeDA recovered patterns consistent with the original publications while surfacing additional literature-supported findings, suggesting the integrated workflow can add value without discarding established results.

Accessibility is a stated design goal. The platform features an interactive web interface and requires no programming expertise, lowering the barrier for clinical researchers and experimentalists who lack bioinformatics support. The open-source release, published under a Creative Commons Attribution 4.0 license, includes the Docker image for local deployment, an option likely to appeal to institutions handling sensitive clinical data. As microbiome studies grow in scale and increasingly pool cohorts across laboratories, tools that treat compositionality and batch structure as first-class citizens, rather than afterthoughts, may become essential infrastructure. CoMeDA’s authors position their platform as a step in that direction: a compositionally coherent workflow in which normalization, batch correction, and downstream analysis follow a single, consistent analytical logic from raw reads to biological interpretation.

Subject of Research: An integrated web platform for compositional analysis and batch correction of metabarcoding data

Article Title: CoMeDA: an integrated platform for compositional analysis of metabarcoding data with batch correction

Article References: CoMeDA: an integrated platform for compositional analysis of metabarcoding data with batch correction. (n.d.). https://doi.org/10.1186/s12859-026-06705-8

Image Credits: AI Generated

DOI: 10.1186/s12859-026-06705-8

Keywords: metabarcoding, microbiome, compositional data analysis, batch effect correction, 16S rRNA, ITS sequencing, CLR transformation, differential abundance, co-occurrence networks, cross-kingdom analysis, bioinformatics software, long-read sequencing

News Source: Morgan Morrow. (October 14, 2026). CoMeDA Brings Compositional Rigor and Batch Correction to Microbiome Analysis. Scienmag.

Tags: 16S rRNAbatch effect correctionbioinformatics softwareCLR transformationco-occurrence networksCompositional data analysiscross-kingdom analysisdifferential abundanceITS sequencinglong-read sequencingmetabarcodingMicrobiome
Share12Tweet7Share2ShareShareShare1

Related Posts

Gene Therapy Shows Proof of Concept for Treating Hydrocephalus at Its Source

Gene Therapy Shows Proof of Concept for Treating Hydrocephalus at Its Source

October 14, 2026
Oxytocin in the Brain's Septum Lets Mice Learn Safe Foods From Friends

Oxytocin in the Brain’s Septum Lets Mice Learn Safe Foods From Friends

October 14, 2026

Sick Leeches Keep Their Microbial Diversity but Lose Their Microbial Stability

October 14, 2026

Tumor Twins: Living Lab-Grown Cancer Copies Paired With AI Could Transform Breast Cancer Treatment

October 14, 2026

POPULAR NEWS

  • Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    29 shares
    Share 12 Tweet 7
  • Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

    29 shares
    Share 12 Tweet 7
  • Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

    29 shares
    Share 12 Tweet 7
  • New Scale Measures How Ready Nurse Educators Really Are for the AI Era

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.